<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02265497</url>
  </required_header>
  <id_info>
    <org_study_id>Relinfo</org_study_id>
    <nct_id>NCT02265497</nct_id>
  </id_info>
  <brief_title>Brazilian Network for Lymphoma Registry</brief_title>
  <acronym>Relinfo</acronym>
  <official_title>Brazilian Network for Lymphoma Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Claudio Gustavo Stefanoff</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Adriana Alves de Souza Scheliga</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Claudete Esteves Nogueira Pinto Klumb</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ricardo de Sá Bigni</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Luciana Wernersbach Pinto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rocio Hassan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Isabele Avila Small</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Monik Mariano Pinto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cecilia Ferreira da Silva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Nacional de Cancer, Brazil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently there are no official data concerning incidence, progression and prognosis of
      patients with lymphoma in Brazil.This project aims the establishment of a network of 12
      Brazilian Institutions to implement a Lymphoma Registry (RELINFO) with the Brazilian National
      Cancer Institute (INCA) as the Coordinating Center.We intend to develop and implement a
      computerized system for data entry and information management of patients with lymphomas.
      This will enable create a virtual registry of demographic, clinical, epidemiological,
      histopathological, molecular, and therapeutic data. This clinical record must be linked to
      histopathological and molecular diagnosis, allowing institutions that work in the context of
      the public health system have access to new technologies for early cancer diagnosis.We expect
      is that this record reliably portrays the scene of lymphomas in our state and will become a
      management model that can be replicated at the national level. Thus, the implementation of
      RELINFO will strengthen the multidisciplinary diagnosis, promote the standardization of
      clinical record of patients with lymphomas and provide subsidies to cooperative research
      projects between participating institutions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data collection and management:

      For data collection will use a common system for all institutions participating.We developed
      a computerized tool that utilizes models of case report forms (CRF) and allows the inclusion
      and management of clinical, epidemiological, histopathological and molecular data. The
      clinical and laboratory data of patients included in RELINFO will be obtained from the
      hospital records. The integration of local databases allows constitute the RELINFO, conceived
      as a virtual database of patients with lymphoma. The INCA as Coordinating Center is committed
      to the security of this database.Standardization of diagnosisThis phase includes structuring
      a technological platform for the standardization of histopathologic diagnosis (establishing
      common routines in hematopathology) and the incorporation of molecular methods in the
      diagnosis of lymphoma.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>24 Months</target_duration>
  <primary_outcome>
    <measure>rate of incidence of lymphomas in Brazil</measure>
    <time_frame>6 years</time_frame>
    <description>Identify the current situation of lymphomas, through the deployment of a Lymphoma Registry in cancer treatment centers of Rio de Janeiro, Brazil</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>epidemiological characterization of lymphomas in Brazil</measure>
    <time_frame>6 years</time_frame>
    <description>description of demographic, clinical, epidemiological, histopathological, molecular, and therapeutic data of lymphoma patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>establishing common routines in hematopathology</measure>
    <time_frame>6 years</time_frame>
    <description>Structure a technology platform that allows the standardization of histopathological diagnosis and the incorporation of molecular methods in the diagnosis of lymphoma.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">550</enrollment>
  <condition>Lymphoma</condition>
  <arm_group>
    <arm_group_label>Hodgkin's or non-Hodgkin lymphoma</arm_group_label>
    <description>All patients with diagnoses of Hodgkin's or non-Hodgkin lymphoma with available with available clinical, histopathology and treatment data.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with diagnosis of Hodgkin's or non-Hodgkin lymphoma with available with
        available clinical, histopathology and treatment data.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients (adult or child) with diagnosis of Hodgkin's or non-Hodgkin lymphoma with
             available with available clinical, histopathology and treatment data

          -  Patient enrolled on study sites included on this project

        Exclusion Criteria:

          -  Patients (adult or child) with other diagnoses of cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudio Gustavo Stefanoff, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Instituto Nacional de Cancer, Brazil</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claudio Gustavo Stefanoff, doctor</last_name>
    <phone>+55 21 32076541</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cecilia F Silva, Master</last_name>
    <phone>+55 21 32076601</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Brazilian National Cancer Institute - INCA/ Ministry Of HealthClinical Research Department</name>
      <address>
        <city>Rio de Janeiro</city>
        <state>RJ</state>
        <zip>20231-050</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudio Gustavo Stefanoof, Doctor</last_name>
      <phone>+55 21 32076541</phone>
    </contact>
    <contact_backup>
      <last_name>Adriana A Scheliga, Master</last_name>
      <phone>+55 21 32076585</phone>
    </contact_backup>
    <investigator>
      <last_name>Adilson José Almeida</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Monica Praxedes</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fernando M Pinto</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rita Elizabete G Espariz</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luciana Conti</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Glaucia Guasti</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juliana G Musacchio</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leonardo G Leite</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2014</study_first_submitted>
  <study_first_submitted_qc>October 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2014</study_first_posted>
  <last_update_submitted>August 15, 2017</last_update_submitted>
  <last_update_submitted_qc>August 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Cancer, Brazil</investigator_affiliation>
    <investigator_full_name>Claudio Gustavo Stefanoff</investigator_full_name>
    <investigator_title>Claudio Gustavo Stefanoff</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

